The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Carotid intima-media thickness for cardiovascular risk assessment: Systematic review and meta-analysis

(2013) Stijn C.H. van den Oord et al.   ATHEROSCLEROSIS

The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women

(2013) Geeta Hampson et al.   BONE

Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels

(2013) S. Morales-Santana et al.   DIABETES CARE

Wnt signaling in the vasculature

(2013) Marco Reis et al.   EXPERIMENTAL CELL RESEARCH

Sclerostin: Another Vascular Calcification Inhibitor?

(2013) Kathleen J. Claes et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Wnt signaling in bone formation and its therapeutic potential for bone diseases

(2013) Jeong Hwan Kim et al.   Therapeutic Advances in Musculoskeletal Disease

Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness

(2012) S. Thambiah et al.   CALCIFIED TISSUE INTERNATIONAL

Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus

(2012) A H van Lierop et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus

(2012) Agostino Gaudio et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes

(2012) Luigi Gennari et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus

(2011) Antonia García-Martín et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cellular and molecular mechanisms of vascular injury in diabetes — Part I: Pathways of vascular disease in diabetes

(2011) Rosalinda Madonna et al.   VASCULAR PHARMACOLOGY

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men

(2010) Ulrike I Mödder et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Carotid Intima-Media Thickness and Presence or Absence of Plaque Improves Prediction of Coronary Heart Disease Risk

(2010) Vijay Nambi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

MMP-9 and -12 cause N-cadherin shedding and thereby β-catenin signalling and vascular smooth muscle cell proliferation

(2008) Amrita Dwivedi et al.   CARDIOVASCULAR RESEARCH